Are you a clinical scientist looking to get your research seen by a wider audience? 💡 Submit your work to @uegjournal & share your findings with digestive healthcare professionals around the world.
🔗 Find out more: https://t.co/lax19TiF8r
#myUEGcommunity#weareUEG#UEGJ
🆕 in UEG Journal
Prospective 24 week study included 24 patients
No incidence of spondylarthritis in either tumor necrosis factor inhibitor alpha naïve or experienced patients occurred after initiating vedolizumab
@WileyHealth@my_ueg@joostphdrenth
https://t.co/vz7OScwoIk
✴️ 43.6% of fecal VOCs decreased in Crohn's (CD) or ulcerative colitis (UC).
📊 Oct-1-en-3-ol rose in CD and UC, then fell in UC with treatment.
💩Fecal VOCs aid non-invasive IBD diagnosis
@WileyHealth@my_ueg@joostphdrenth
https://t.co/VRGAHSnBgD
Quality of clinical guidelines: It matters as it impacts patient care!🏥
We evaluated 16 guidelines recently published at #ueg journal, results
underscore the need of sound, standardized and transparant development methods for future guidelines.
👉🏼https://t.co/cLDrgVoPIK
@UEGJournal editors want to get your view of what constitutes high-quality guidelines!
Please take part in this survey: https://t.co/aJE4BvzXGv
#myUEGcommunity#weareUEG#UEGJ
Hey @Y_ECCO_IBD@ehmsg@ESGE_news
🥇What makes a high-quality clinical guideline?
🏥Do you use guidelines in your practice?
🤝What earns a guideline your trust?
4 weeks to go!!
⬆️ Compliance: H. pylori eradication treatment has a 98.3% adherence
⬇️ Compliance: Linked to dyspepsia, rescue treatments, longer prescriptions, adverse events, and complex therapies
✴️ Success Correlation: Adherence is key to successful eradication
https://t.co/4DlGO0IXnZ
🆕Review Article
📊MASLD is on the rise
🧬Genetic variants help stratify risk
✔️Genetic-based tools diagnose and predict MASLD outcomes
✴️Current tools lack optimal accuracy
🤖AI could enhance decision-making algorithms in MASLD treatment
https://t.co/Txhp1sdM80
Do you read or have ever developed a clinical guideline?
We need your opinion!
We are looking into readers' / users' perspectives of what consitutes a quality clinical guideline.
Please fill out this survey below:
@ILevink takes a “juicy “ view of #pancreaticcancer
🧐Zeroing in on biomarkers
🎯 The infamous Ca19.9
📢 message elevated if cancer but doesn’t distinguish between early stages
✌️Kudos for this superb PhD thesis
@erasmusmcintl@Gio_Marchegiani https://t.co/W0YXq15Jzm